Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Advancing usability of an influenza hemagglutinin virus-like particle vaccine expressing a chimeric cytokine ; volume:20 ; number:1 ; day:26 ; month:5 ; year:2023 ; pages:1-8 ; date:12.2023
Virology journal ; 20, Heft 1 (26.5.2023), 1-8, 12.2023
- Creator
-
Imagawa, Toshifumi
Arasaki, Youta
Maegawa, Kenichi
Sugita, Shigeo
Nerome, Kuniaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12985-023-02076-1
- URN
-
urn:nbn:de:101:1-2023091108230164086590
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Imagawa, Toshifumi
- Arasaki, Youta
- Maegawa, Kenichi
- Sugita, Shigeo
- Nerome, Kuniaki
- SpringerLink (Online service)
Other Objects (12)
Purification of a chimeric virus-like particle from a complex culture medium
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Purification of a chimeric virus-like particle from a complex culture medium
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice
T cells expressing NKG2D chimeric antigen receptors efficiently eliminate glioblastoma and cancer stem cells
Purification of a chimeric virus-like particle from a complex culture medium
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus
A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates
Identification and selective expansion of functionally superior T cells expressing chimeric antigen receptors
Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged mice